Find consortia

Results Download Results in Excel (.XLS)


Consortium title & disease focus Tool Development

Tools

Biomarker Research

Biomarker

Basic Research

Basic

Data-Sharing
Enabler

Data

Product Development

Products

Addario Lung Cancer Consortium
Lung Cancer
ADDPLAN DF Consortium
Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
Pain
CHILD-INNOVAC (Nasal Vaccination Against Respiratory Infections in Young Children)
Respiratory Conditions
Clinical Trials Transformation Initiative (CTTI)
Combatting Bacterial Resistance in Europe (COMBACTE)
Bacterial Resistance
Critical Path to TB Drug Regimens (CPTR)
Tuberculosis
Dementias Research Platform UK
Dementias
Dual Antiplatelet Therapy (DAPT) Study
Electronic Patient-Reported Outcome (ePRO) Consortium
European Clinical Research Infrastructures Network (ECRIN)
European LuekemiaNet (ELN)
Leukaemia
European Microbicides Project (EMPRO)
HIV/AIDS
International Thyroid Oncology Group (ITOG)
Thyroid Cancer
Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2 (I-SPY 2)
Oncology
Investigator Databank
Lung Cancer Master Protocol (Lung-MAP)
Squamous Lung Cancer
Metrics Champion Consortium (MCC)
Multiple Sclerosis Outcome Assessments Consortium (MSOAC)
Multiple Sclerosis
National Lung Matrix Trial (NLM)
Oncology
NeuroNEXT
Neurological conditions
Patients to Trials Consortium
Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT)
RESPECT Patient Needs
Stamford Therapeutics Consortium
Synodos for NF2
Neurofibromatosis
The Avoca Quality Consortium
The Forum for Collaborative HIV Research
Hiv, Hepatitis C, Viral Hepatitis...
The Neurofibromatosis Therapeutic Consortium (NFTC)
Neurofibromatosis
The Personal Genome Sequencing Outcomes (PeopleSeq) Consortium
The Prostate Cancer Clinical Trials Consortium (PCCTC)
Prostate Cancer
The Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS)
Neurofibromatosis
TransCelerate BioPharma
Worldwide Innovative Networking Consortium
Oncology

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.